Blocking IL-4, which suppresses IL-12 production, in NSCLC mouse models augmented cytokine production by CD4+ T cells activated by mregDCs, resulting in reduced tumor growth and an increased expansion of IFNγ+TNF+CD8+ T cells (22). The gene discussed is CD8A; the disease is neoplasm.